BUY Aurobindo Pharma — Prakash Gaba
byPrakash GabaHorizon: NA (inferred Intraday)4 Nov 2026, 9:11 am ISTvia CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·30 Oct · 5d ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Aurobindo Pharma
- BUY — Nuvama Wealth6 Nov 2026 · ~1 year · target ₹2,195 · Active
- BUY — Goldman Sachs6 Nov 2026 · ~1 year · target ₹2,000 · Active
- SELL — Citigroup5 Nov 2026 · ~1 year · target ₹1,270 · Active
- BUY — Raja Venkatraman5 Nov 2026 · ~3 months · target ₹1,875 · Active
- BUY — Elara Capital4 Nov 2026 · ~1 year · target ₹2,180 · Active
More from Prakash Gaba
- BUY Neogen Chemicals6 Nov 2026 · ~2 weeks · target ₹2,625 · Active
- BUY Axis Bank6 Nov 2026 · ~2 weeks · target ₹1,320 · Target hit
- BUY VA Tech Wabag6 Nov 2026 · ~2 weeks · target ₹2,050 · SL hit
- BUY VA Tech Wabag6 Nov 2026 · ~2 weeks · target ₹2,150 · Active
- BUY Titan Company6 Nov 2026 · Same day · target ₹5,000 · Target hit

